Az instabil coronaria arteria betegség kezelése.

Translated title of the contribution: Treatment of unstable coronary disease

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The clinical presentations of ischemic heart disease comprises the term of acute ischaemia syndromes, that include unstable angina pectoris, non-Q-wave myocardial infarction, Q-wave-myocardial infarction and sudden death. Among the different presentations of acute ischemic syndromes, the unstable angina and non-Q-wave myocardial infarction can be regarded together. In both pathologic entity, the plaque rupture, or erosion signifies the primary event, which is the source of the highly thrombogenic substances coming out from the core of the atherosclerotic plaque and entering to the coronary and systemic circulation. They cause a thrombocyte-rich "white" intracoronary thrombus, that is not fully obstructive, or there is adequate collateral circulation, being the pathogenetic substrate that prevents the development of transmural necrosis. The nosologically-bound two clinical entity can be called as "unstable coronary artery disease" (UCAD), since they have uniform etiologic, risk stratification and therapeutic backgrounds and also therapeutic targets that are basically distinct, they are admitted for transmural "ST-elevation" infarction. The review is discussing the therapy and the questions of follow-up of the disease according to the guidelines of the European Society of Cardiology and to the multicenter evidence based studies.

Original languageHungarian
Pages (from-to)757-765
Number of pages9
JournalOrvosi Hetilap
Volume143
Issue number15
Publication statusPublished - Apr 14 2002

Fingerprint

Coronary Disease
Myocardial Infarction
Unstable Angina
Coronary Circulation
Collateral Circulation
Atherosclerotic Plaques
Sudden Death
Infarction
Myocardial Ischemia
Coronary Artery Disease
Rupture
Thrombosis
Necrosis
Therapeutics
Blood Platelets
Ischemia
Guidelines

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Az instabil coronaria arteria betegség kezelése. / Préda, I.

In: Orvosi Hetilap, Vol. 143, No. 15, 14.04.2002, p. 757-765.

Research output: Contribution to journalArticle

@article{f44d081433ac48688d4dcf070789d18f,
title = "Az instabil coronaria arteria betegs{\'e}g kezel{\'e}se.",
abstract = "The clinical presentations of ischemic heart disease comprises the term of acute ischaemia syndromes, that include unstable angina pectoris, non-Q-wave myocardial infarction, Q-wave-myocardial infarction and sudden death. Among the different presentations of acute ischemic syndromes, the unstable angina and non-Q-wave myocardial infarction can be regarded together. In both pathologic entity, the plaque rupture, or erosion signifies the primary event, which is the source of the highly thrombogenic substances coming out from the core of the atherosclerotic plaque and entering to the coronary and systemic circulation. They cause a thrombocyte-rich {"}white{"} intracoronary thrombus, that is not fully obstructive, or there is adequate collateral circulation, being the pathogenetic substrate that prevents the development of transmural necrosis. The nosologically-bound two clinical entity can be called as {"}unstable coronary artery disease{"} (UCAD), since they have uniform etiologic, risk stratification and therapeutic backgrounds and also therapeutic targets that are basically distinct, they are admitted for transmural {"}ST-elevation{"} infarction. The review is discussing the therapy and the questions of follow-up of the disease according to the guidelines of the European Society of Cardiology and to the multicenter evidence based studies.",
author = "I. Pr{\'e}da",
year = "2002",
month = "4",
day = "14",
language = "Hungarian",
volume = "143",
pages = "757--765",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "15",

}

TY - JOUR

T1 - Az instabil coronaria arteria betegség kezelése.

AU - Préda, I.

PY - 2002/4/14

Y1 - 2002/4/14

N2 - The clinical presentations of ischemic heart disease comprises the term of acute ischaemia syndromes, that include unstable angina pectoris, non-Q-wave myocardial infarction, Q-wave-myocardial infarction and sudden death. Among the different presentations of acute ischemic syndromes, the unstable angina and non-Q-wave myocardial infarction can be regarded together. In both pathologic entity, the plaque rupture, or erosion signifies the primary event, which is the source of the highly thrombogenic substances coming out from the core of the atherosclerotic plaque and entering to the coronary and systemic circulation. They cause a thrombocyte-rich "white" intracoronary thrombus, that is not fully obstructive, or there is adequate collateral circulation, being the pathogenetic substrate that prevents the development of transmural necrosis. The nosologically-bound two clinical entity can be called as "unstable coronary artery disease" (UCAD), since they have uniform etiologic, risk stratification and therapeutic backgrounds and also therapeutic targets that are basically distinct, they are admitted for transmural "ST-elevation" infarction. The review is discussing the therapy and the questions of follow-up of the disease according to the guidelines of the European Society of Cardiology and to the multicenter evidence based studies.

AB - The clinical presentations of ischemic heart disease comprises the term of acute ischaemia syndromes, that include unstable angina pectoris, non-Q-wave myocardial infarction, Q-wave-myocardial infarction and sudden death. Among the different presentations of acute ischemic syndromes, the unstable angina and non-Q-wave myocardial infarction can be regarded together. In both pathologic entity, the plaque rupture, or erosion signifies the primary event, which is the source of the highly thrombogenic substances coming out from the core of the atherosclerotic plaque and entering to the coronary and systemic circulation. They cause a thrombocyte-rich "white" intracoronary thrombus, that is not fully obstructive, or there is adequate collateral circulation, being the pathogenetic substrate that prevents the development of transmural necrosis. The nosologically-bound two clinical entity can be called as "unstable coronary artery disease" (UCAD), since they have uniform etiologic, risk stratification and therapeutic backgrounds and also therapeutic targets that are basically distinct, they are admitted for transmural "ST-elevation" infarction. The review is discussing the therapy and the questions of follow-up of the disease according to the guidelines of the European Society of Cardiology and to the multicenter evidence based studies.

UR - http://www.scopus.com/inward/record.url?scp=18744426050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18744426050&partnerID=8YFLogxK

M3 - Article

C2 - 11979994

AN - SCOPUS:18744426050

VL - 143

SP - 757

EP - 765

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 15

ER -